Texas Compounding Pharmacy Enters Into Consent Decree Following FDA Lawsuit

(January 6, 2016, 11:52 AM EST) -- DALLAS — A Texas compounding pharmacy on Jan. 4 entered into consent decree of permanent injunction after the Food and Drug Administration on the same day asked a Texas federal court to enjoin Downing Labs LLC and its principals from selling adulterated drugs (United States of America v. Downing Labs, LLC., et al., No. 16-3, N.D. Texas, Dallas Div.).

(Downing complaint available. Document #28-16-0107-020C.)

In a complaint filed in the U.S. District Court for the Northern District of Texas, the FDA says Downing and predecessor NuVision...
To view the full article, register now.